104 related articles for article (PubMed ID: 10815763)
1. Prognostic significance of DNA cytometry in thymoma.
Gripp S; Hilgers K; Ploem-Zaaijer JJ; Hartmann A; Schmitt G
J Cancer Res Clin Oncol; 2000 May; 126(5):280-4. PubMed ID: 10815763
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of the DNA content of thymomas.
Kushibe K; Iioka S; Nezu K; Tojo T; Sawabata N; Kitamura S
Surg Today; 1995; 25(4):334-7. PubMed ID: 7633125
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric analysis of the DNA content in resected thymomas].
Kushibe K; Iioka S; Nezu K; Sawahata A; Tojo H; Kitamura S
Kyobu Geka; 1993 Jan; 46(1):79-83. PubMed ID: 8418365
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of flow cytometric nuclear DNA content of the thymoma and its relationship to malignant intensity].
Yamaoka N; Uchiyama Y; Taniguchi H; Morinaga M; Yamasaki N
Nihon Kyobu Geka Gakkai Zasshi; 1991 Aug; 39(8):1132-8. PubMed ID: 1940514
[TBL] [Abstract][Full Text] [Related]
5. [DNA content analysis and prognostic evaluation of thymoma].
Qu ZS
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):235-7, 255. PubMed ID: 8395320
[TBL] [Abstract][Full Text] [Related]
6. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression.
Mineo TC; Ambrogi V; Mineo D; Baldi A
Cancer; 2005 Nov; 104(10):2063-71. PubMed ID: 16206298
[TBL] [Abstract][Full Text] [Related]
7. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.
Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Cassivi SD; Marks RS; Garces YI; Aubry MC
J Thorac Oncol; 2015 Apr; 10(4):691-700. PubMed ID: 25629638
[TBL] [Abstract][Full Text] [Related]
8. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
9. Flow and image cytometry in thymic neoplasia: correlation with clinical outcome.
Kenny-Moynihan MB; DeRose PB; Gal AA; Chakraborty H; Cohen C
Anal Quant Cytol Histol; 2001 Aug; 23(4):313-20. PubMed ID: 11531146
[TBL] [Abstract][Full Text] [Related]
10. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma.
Koga K; Matsuno Y; Noguchi M; Mukai K; Asamura H; Goya T; Shimosato Y
Pathol Int; 1994 May; 44(5):359-67. PubMed ID: 8044305
[TBL] [Abstract][Full Text] [Related]
11. Thymoma. The prognostic significance of flow cytometric DNA analysis.
Pollack A; el-Naggar AK; Cox JD; Ro JY; Sahin A; Komaki R
Cancer; 1992 Apr; 69(7):1702-9. PubMed ID: 1551054
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of DNA flow cytometry in thymomas and thymic carcinomas.
Sauter ER; Sardi A; Hollier LH; Cooper ES; Bolton JS
South Med J; 1990 Jun; 83(6):656-9. PubMed ID: 2356499
[TBL] [Abstract][Full Text] [Related]
13. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.
Ruffini E; Filosso PL; Mossetti C; Bruna MC; Novero D; Lista P; Casadio C; Oliaro A
Eur J Cardiothorac Surg; 2011 Jul; 40(1):146-53. PubMed ID: 21093283
[TBL] [Abstract][Full Text] [Related]
14. Thymoma: prognostic factors and treatment outcomes.
Gripp S; Hilgers K; Wurm R; Schmitt G
Cancer; 1998 Oct; 83(8):1495-503. PubMed ID: 9781943
[TBL] [Abstract][Full Text] [Related]
15. Thymoma: a multivariate analysis of factors predicting survival.
Blumberg D; Port JL; Weksler B; Delgado R; Rosai J; Bains MS; Ginsberg RJ; Martini N; McCormack PM; Rusch V
Ann Thorac Surg; 1995 Oct; 60(4):908-13; discussion 914. PubMed ID: 7574993
[TBL] [Abstract][Full Text] [Related]
16. [Thymoma-report of 166 patients].
Ge D; Zheng R; Fan H
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):503-4. PubMed ID: 11859722
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
[TBL] [Abstract][Full Text] [Related]
18. [Grading of malignancy of thymomas by flow cytometry].
Liu H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Aug; 14(4):310-3. PubMed ID: 1473222
[TBL] [Abstract][Full Text] [Related]
19. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.
Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
Am J Pathol; 1988 Dec; 133(3):615-22. PubMed ID: 3202120
[TBL] [Abstract][Full Text] [Related]
20. Predictors of survival following surgical resection of thymoma.
McCart JA; Gaspar L; Inculet R; Casson AG
J Surg Oncol; 1993 Dec; 54(4):233-8. PubMed ID: 8255084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
